Ironwood Pharmaceuticals, Inc

(NASDAQ:IRWD)

Latest On Ironwood Pharmaceuticals, Inc (IRWD):

Date/Time Type Description Signal Details
2023-05-22 08:54 ESTNewsIronwood falls 15% on deal to buy VectivBio for $17/share cashN/A
2023-05-07 06:21 ESTNewsIronwood Pharmaceuticals, Inc. (IRWD) Q1 2023 Earnings Call TranscriptN/A
2023-05-04 13:18 ESTNewsIronwood Pharmaceuticals Non-GAAP EPS of $0.25 beats by $0.01, revenue of $104.06M beats by $3.46MN/A
2023-05-04 00:56 ESTNewsIronwood Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-04-13 22:50 ESTNewsIronwood Pharmaceuticals gains amid activist speculationN/A
2023-04-11 15:09 ESTNewsIronwood Pharmaceuticals to eliminate COO roleN/A
2023-02-16 14:50 ESTNewsIronwood Pharmaceuticals Non-GAAP EPS of $0.27 beats by $0.01, revenue of $107.2M misses by $1.02M, guidance in-lineN/A
2023-02-16 14:50 ESTNewsIronwood Pharmaceuticals, Inc. 2022 Q4 - Results - Earnings Call PresentationN/A
2023-02-16 14:49 ESTNewsIronwood Pharmaceuticals, Inc. (IRWD) Q4 2022 Earnings Call TranscriptN/A
2023-02-13 07:56 ESTNewsAbbVie, Ironwood Linzess gets FDA priority review to treat functional constipation in childrenN/A
2023-01-12 23:21 ESTNewsIronwood Pharmaceuticals (IRWD) Presents at the 41st Annual J.P. Morgan Healthcare Conference -- SlideshowN/A
2022-11-04 04:11 ESTNewsIronwood Pharmaceuticals, Inc. (IRWD) Q3 2022 Earnings Call TranscriptN/A
2022-11-03 10:50 ESTNewsIronwood Pharmaceuticals Non-GAAP EPS of $0.28 beats by $0.01, revenue of $108.64M misses by $1.76M, reaffirms FY guidanceN/A
2022-10-05 22:54 ESTNewsIronwood Pharmaceuticals: Rinse, Wash And RepeatN/A
2022-09-06 10:21 ESTNewsAbbVie, Ironwood constipation therapy Linzess meets main goal of phase 3 trial in childrenN/A
2022-08-06 10:54 ESTNewsIronwood Pharmaceuticals, Inc. (IRWD) CEO Tom McCourt on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-05 19:46 ESTNewsIronwood Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-04 12:40 ESTNewsIronwood Pharmaceuticals reports Q2 earnings miss; reaffirms FY22 guidanceN/A
2022-08-03 22:08 ESTNewsIronwood Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-07-30 04:58 ESTNewsIronwood Pharma falls 7% as Linzess Q2 sales of drug from AbbVie weighN/A
2022-05-08 17:53 ESTNewsIronwood Pharmaceuticals, Inc. (IRWD) CEO Tom McCourt on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-06 04:09 ESTNewsIronwood Pharmaceuticals Non-GAAP EPS of $0.21, revenue of $98MN/A
2022-05-05 04:57 ESTNewsIronwood Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-04-22 13:29 ESTNewsIronwood Pharmaceuticals initiated at overweight at Piper on cash flow from LinzessN/A
2022-02-18 16:15 ESTNewsIronwood Pharmaceuticals, Inc.'s (IRWD) CEO Thomas McCourt on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-17 19:01 ESTNewsIronwood Pharmaceuticals Non-GAAP EPS of $0.27 misses by $0.07, revenue of $117.13M beats by $6.96MN/A
2022-02-17 19:01 ESTNewsIronwood Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-02-17 19:01 ESTNewsIronwood Pharmaceuticals, Inc. (IRWD) CEO Thomas McCourt on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-16 22:26 ESTNewsIronwood Pharmaceuticals Q4 2021 Earnings PreviewN/A
2022-01-15 01:26 ESTNewsIronwood Pharmaceuticals (IRWD) presents at JP Morgan 40th Annual Virtual Healthcare Conference (Slideshow)N/A
2022-01-10 21:10 ESTNewsIronwood Pharmaceuticals sees FY21 guidance ahead of prior levels, provides FY22 estimatesN/A
2021-12-01 23:58 ESTNewsIronwood names Sravan Emany as CFON/A
2021-12-01 23:57 ESTNewsIronwood Pharmaceuticals gains on takeout speculation with CFO hiringN/A
2021-11-06 22:18 ESTNewsIronwood Pharmaceuticals, Inc. (IRWD) CEO Tom McCourt on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-05 08:07 ESTNewsIronwood Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-04 11:05 ESTNewsIronwood Pharmaceuticals EPS beats by $0.01, misses on revenueN/A
2021-11-04 11:05 ESTNewsIronwood inks collaboration and license option agreement with COUR PharmaceuticalN/A
2021-11-03 13:59 ESTNewsIronwood Pharmaceuticals Q3 2021 Earnings PreviewN/A
2021-09-27 19:35 ESTNewsIronwood Pharmaceuticals: Undervalued Company With Steady GrowthN/A
2021-08-26 14:54 ESTNewsIronwood Pharma pops 7% on FDA approval of revised Lizness labelN/A
2021-08-10 06:03 ESTNewsIronwood Pharmaceuticals, Inc. 2021 Q2 - Results - Earnings Call PresentationN/A
2021-08-08 14:03 ESTNewsIronwood Pharmaceuticals, Inc. (IRWD) CEO Tom McCourt on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-06 05:08 ESTNewsIronwood Pharmaceuticals EPS beats by $0.12, beats on revenueN/A
2021-08-05 06:49 ESTNewsIronwood Pharmaceuticals Q2 2021 Earnings PreviewN/A
2021-07-21 12:48 ESTNewsIronwood Pharma announces agreement with Teva for generic version of LINZESSN/A
2021-07-21 12:45 ESTNewsIronwood Pharmaceuticals names Thomas McCourt permanent CEON/A
2021-07-21 12:33 ESTNewsIronwood Pharmaceuticals gains on takeover speculation after 8-K filing (update)N/A
2021-05-06 14:04 ESTNewsIronwood Pharmaceuticals EPS beats by $0.03, misses on revenue; reaffirms guidanceN/A
2021-05-06 14:04 ESTNewsIronwood Pharmaceuticals announces $150M share buybackN/A
2021-05-05 18:07 ESTNewsIronwood Pharmaceuticals Q1 2021 Earnings PreviewN/A

About Ironwood Pharmaceuticals, Inc (IRWD):

Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. The company is also developing IW-3300, a GC-C agonist, which is in pre-clinical development for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis. It has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.

See Advanced Chart

General

  • Name Ironwood Pharmaceuticals, Inc
  • Symbol IRWD
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 232
  • Last Split Factor1194:1000
  • Last Split Date2019-04-02
  • Fiscal Year EndDecember
  • IPO Date2010-02-03
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.ironwoodpharma.com
View More

Valuation

  • Trailing PE 17
  • Forward PE 10.86
  • Price/Sales (Trailing 12 Mt.) 4.76
  • Price/Book (Most Recent Quarter) 29.63
  • Enterprise Value Revenue 5
  • Enterprise Value EBITDA 13.72
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $0.96
  • Next Year EPS Estimate $1.05
  • Next Quarter EPS Estimate $0.19
  • Profit Margin 27%
  • Operating Margin 41%
  • Return on Assets 21%
  • Revenue 389.52 million
  • Earnings Per Share $0.66
  • Revenue Per Share $2.44
  • Gross Profit 298.33 million
  • Quarterly Earnings Growth -7.6%
View More

Highlights

  • Market Capitalization 1.81 billion
  • EBITDA 161.29 million
  • PE Ratio 87.74
  • PEG Ratio -0.26
  • Analyst Target Price $11
  • Book Value Per Share $0.39
View More

Share Statistics

  • Shares Outstanding 160.96 million
  • Shares Float 140.01 million
  • % Held by Insiders 296%
  • % Held by Institutions 108.52%
  • Shares Short 17.91 million
  • Shares Short Prior Month 18.17 million
  • Short Ratio 9.23
  • Short % of Float 17%
  • Short % of Shares Outstanding 11%
View More

Technicals

  • Beta 1.35
  • 52 Week High $12.55
  • 52 Week Low $8.63
  • 50 Day Moving Average 10.2
  • 200 Day Moving Average 10.57
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Ironwood Pharmaceuticals, Inc (IRWD) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Ironwood Pharmaceuticals, Inc (IRWD) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-17$116.68 million$0.36$0.2925%
2020-09-302020-11-05$103.47 million$0.23$0.1551.32%
2020-06-302020-08-06$N/A$0.16$0.1056.1%
2020-03-312020-05-06$79.94 million$0.04$0.05-13.04%
2019-12-312020-02-13$126.3 million$0.30$0.2425%
2019-09-302019-10-31$131.17 million$0.40$0.12241.01%
2019-06-302019-07-30$102.22 million$0.10-$0.03500%
2019-03-312019-05-02$68.73 million-$0.26-$0.23-14.69%
2018-12-312019-02-13$130.69 million-$0.02-$0.1989.38%
2018-09-302018-11-06$65.69 million-$0.38-$0.20-91.63%
2018-06-302018-08-06$81.11 million-$0.28-$0.23-24.06%
2018-03-312018-05-01$69.16 million-$0.27-$0.21-25.99%
2017-12-312018-02-15$94.21 million-$0.14-$0.2031.57%
2017-09-302017-11-02$86.83 million-$0.18-$0.2425.37%
2017-06-302017-08-03$65.08 million-$0.28-$0.23-22.32%
2017-03-312017-05-08$52.17 million-$0.33-$0.21-53.99%
2016-12-312017-02-21$87.46 million-$0.12-$0.2246.07%
2016-09-302016-11-03$66.11 million-$0.18-$0.2322.21%
2016-06-302016-08-04$54.35 million-$0.16-$0.160.81%
2016-03-312016-05-09$66.04 million-$0.08-$0.1751.54%
2015-12-312016-02-18$53.31 million-$0.10-$0.1843.05%
2015-09-302015-11-03$39.57 million-$0.33-$0.20-65%
2015-06-302015-08-05$27.74 million-$0.34-$0.22-54.55%
2015-03-312015-05-05$28.93 million-$0.24-$0.23-4.35%
2014-12-312015-02-12$38.07 million-$0.27-$0.21-28.57%
2014-09-302014-11-04$16.92 million-$0.30-$0.326.25%
2014-06-302014-08-04$6.84 million-$0.44-$0.36-22.22%
2014-03-312014-04-29$14.61 million-$0.38-$0.4311.63%
2013-12-312014-01-21$5.03 million-$0.43-$0.5014%
2013-09-302013-10-22$4.93 million-$0.51-$0.5710.53%
2013-06-302013-07-23$9.66 million-$0.57-$0.6816.18%
2013-03-312013-04-23$3.26 million-$0.82-$0.64-28.13%
2012-12-312013-01-15$26.98 million-$0.41-$0.4712.77%
2012-09-302012-10-16$96.41 million$0.42$0.13223.08%
2012-06-302012-07-17$14.6 million-$0.38-$0.32-18.75%
2012-03-312012-05-01$12.25 million-$0.34-$0.24-41.67%
2011-12-312012-02-28$32.15 million-$0.07-$0.1136.36%
2011-09-302011-11-07$12.22 million-$0.21-$0.210%
2011-06-302011-08-11$11.26 million-$0.19-$0.190%
2011-03-312011-05-12$10.24 million-$0.19-$0.17-11.76%
2010-12-312011-03-03$16.77 million-$0.12-$0.1414.29%
2010-09-302010-11-04$9.06 million-$0.08-$0.1957.89%
2010-06-302010-08-05$9.19 million-$0.18-$0.195.26%
2010-03-312010-05-11$8.84 million-$0.25-$0.16-56.25%
2009-12-312010-03-30$8.4 million-$3.30-$0.20-1550%

Ironwood Pharmaceuticals, Inc (IRWD) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Ironwood Pharmaceuticals, Inc (IRWD) Chart:

Ironwood Pharmaceuticals, Inc (IRWD) News:

Below you will find a list of latest news for Ironwood Pharmaceuticals, Inc (IRWD) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Ironwood Pharmaceuticals, Inc (IRWD) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-01-1610CALL0 0435.98TRUE00
2026-01-162.51.09CALL0 44182.56TRUE00
2026-01-1640.25CALL31 82152.35FALSE0.250
2026-01-1650.1CALL0 25255.86FALSE00
2026-01-1660CALL0 0477.04FALSE00
2026-01-167.50.15CALL0 2524.79FALSE00
2026-01-1610PUT0 00FALSE00
2026-01-162.50.29PUT0 36452.65FALSE00
2026-01-1640.8PUT0 5140.86TRUE00
2026-01-1651.5PUT0 50TRUE00
2026-01-1660PUT0 00TRUE00
2026-01-167.50PUT0 00TRUE00
2026-02-200.52.7CALL1 312342.23TRUE2.70
2026-02-2012.5CALL0 383333.75TRUE00
2026-02-201.52CALL0 38230TRUE00
2026-02-2021.8CALL0 253207.22TRUE00
2026-02-202.51.27CALL0 1094186.83TRUE00
2026-02-2030CALL0 00TRUE00
2026-02-2040.72CALL0 3227.99FALSE00
2026-02-2050.26CALL5 285138.55FALSE0.260
2026-02-2060CALL0 0314.26FALSE00
2026-02-2070CALL0 00FALSE00
2026-02-207.50.15CALL0 67345.82FALSE00
2026-02-200.50PUT0 00FALSE00
2026-02-2010.15PUT0 129309.43FALSE00
2026-02-201.50.1PUT0 38577.26FALSE00
2026-02-2020.25PUT0 25197.07FALSE00
2026-02-202.50.36PUT0 29300.11FALSE00
2026-02-2030PUT0 00FALSE00
2026-02-2040PUT0 0100.15TRUE00
2026-02-2050PUT0 099.07TRUE00
2026-02-2060PUT0 0103.44TRUE00
2026-02-2070PUT0 0203.51TRUE00
2026-02-207.50PUT0 00TRUE00
2026-05-150.53.14CALL0 7220.17TRUE00
2026-05-1512.72CALL0 29205.39TRUE00
2026-05-151.51.75CALL0 112174.71TRUE00
2026-05-1521.75CALL0 81143.36TRUE00
2026-05-152.51.24CALL0 127148.7TRUE00
2026-05-1541.01CALL0 6137.9FALSE00
2026-05-1550.69CALL10 702146.15FALSE0.060.1
2026-05-1560CALL0 0159.53FALSE00
2026-05-1570.4CALL2 0140.76FALSE0.40
2026-05-157.50.25CALL25 90124.28FALSE0.250
2026-05-150.50PUT0 00FALSE00
2026-05-1510.38PUT0 50FALSE00
2026-05-151.50.48PUT0 5379.27FALSE00
2026-05-1520.3PUT0 165144.8FALSE00
2026-05-152.50.5PUT50 61114.38FALSE0.50
2026-05-1540PUT0 0125.64TRUE00
2026-05-1552.03PUT0 2126.74TRUE00
2026-05-1560PUT0 0125.94TRUE00
2026-05-1570PUT0 0209.71TRUE00
2026-05-157.50PUT0 0124.35TRUE00
2026-08-2110CALL0 0180.97TRUE00
2026-08-2121.9CALL0 39132.96TRUE00
2026-08-2131.42CALL3 10140.73TRUE0.120.09
2026-08-2140CALL0 0141.54FALSE00
2026-08-2150.9CALL0 218132.9FALSE00
2026-08-2160CALL0 0142.33FALSE00
2026-08-2170.2CALL2 0138.85FALSE0.20
2026-08-2110PUT0 00FALSE00
2026-08-2120PUT0 0208.17FALSE00
2026-08-2130PUT0 0114.36FALSE00
2026-08-2140PUT0 0111.72TRUE00
2026-08-2150PUT0 0120.48TRUE00
2026-08-2160PUT0 0121.32TRUE00
2026-08-2170PUT0 0118.27TRUE00

Latest IRWD Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST300$11.685
Jun 13, 2022 7:59 PM EST100$11.68
Jun 13, 2022 7:59 PM EST1$11.68
Jun 13, 2022 7:59 PM EST1$11.67
Jun 13, 2022 7:59 PM EST999$11.67

Ironwood Pharmaceuticals, Inc (IRWD) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120037035/0001209191-20-037035-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1446847/000031506620001036/0000315066-20-001036-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1446847/000083423720005909/0000834237-20-005909-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1446847/000086117720000002/0000861177-20-000002-index.htm
2019-05-16SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1446847/000089914019000402/0000899140-19-000402-index.htm
2020-02-26SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1446847/000089914020000196/0000899140-20-000196-index.htm
2020-01-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1446847/000090221920000252/0000902219-20-000252-index.htm
2019-04-12PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1446847/000104746919002215/0001047469-19-002215-index.htm
2019-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1446847/000104746919002641/0001047469-19-002641-index.htm
2020-04-21DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1446847/000104746920002477/0001047469-20-002477-index.htm
2019-03-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465919013536/0001104659-19-013536-index.htm
2019-03-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000110465919014911/0001104659-19-014911-index.htm
2019-03-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000110465919014912/0001104659-19-014912-index.htm
2019-03-288-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465919018301/0001104659-19-018301-index.htm
2019-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465919019184/0001104659-19-019184-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000110465919019466/0001104659-19-019466-index.htm
2019-04-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465919019969/0001104659-19-019969-index.htm
2019-04-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465919020319/0001104659-19-020319-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465919026217/0001104659-19-026217-index.htm
2019-05-038-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465919026821/0001104659-19-026821-index.htm
2019-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465919029122/0001104659-19-029122-index.htm
2019-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465919033121/0001104659-19-033121-index.htm
2019-05-31S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1446847/000110465919033182/0001104659-19-033182-index.htm
2019-05-31S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1446847/000110465919033185/0001104659-19-033185-index.htm
2019-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465919035369/0001104659-19-035369-index.htm
2019-07-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465919039823/0001104659-19-039823-index.htm
2019-07-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465919041287/0001104659-19-041287-index.htm
2019-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465919042631/0001104659-19-042631-index.htm
2019-10-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465919058066/0001104659-19-058066-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465920003250/0001104659-20-003250-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1446847/000110465920017218/0001104659-20-017218-index.htm
2020-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465920019682/0001104659-20-019682-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465920033605/0001104659-20-033605-index.htm
2020-04-21DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1446847/000110465920049217/0001104659-20-049217-index.htm
2020-04-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465920049220/0001104659-20-049220-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465920057422/0001104659-20-057422-index.htm
2020-06-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465920070834/0001104659-20-070834-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465920091113/0001104659-20-091113-index.htm
2020-09-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465920109500/0001104659-20-109500-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465920121800/0001104659-20-121800-index.htm
2020-11-06S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1446847/000110465920122016/0001104659-20-122016-index.htm
2019-06-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1446847/000114420419030427/0001144204-19-030427-index.htm
2019-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119017301/0001209191-19-017301-index.htm
2019-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119017305/0001209191-19-017305-index.htm
2019-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119017525/0001209191-19-017525-index.htm
2019-03-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119018232/0001209191-19-018232-index.htm
2019-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119020265/0001209191-19-020265-index.htm
2019-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119020268/0001209191-19-020268-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023411/0001209191-19-023411-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023416/0001209191-19-023416-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023419/0001209191-19-023419-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023423/0001209191-19-023423-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023427/0001209191-19-023427-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023429/0001209191-19-023429-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023430/0001209191-19-023430-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023431/0001209191-19-023431-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023433/0001209191-19-023433-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023438/0001209191-19-023438-index.htm
2019-04-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023456/0001209191-19-023456-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023457/0001209191-19-023457-index.htm
2019-04-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023458/0001209191-19-023458-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023459/0001209191-19-023459-index.htm
2019-04-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023462/0001209191-19-023462-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023463/0001209191-19-023463-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023482/0001209191-19-023482-index.htm
2019-05-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119027346/0001209191-19-027346-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119029596/0001209191-19-029596-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119029601/0001209191-19-029601-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119029605/0001209191-19-029605-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119029609/0001209191-19-029609-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119033615/0001209191-19-033615-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119033621/0001209191-19-033621-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119033624/0001209191-19-033624-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119033627/0001209191-19-033627-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119033630/0001209191-19-033630-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119033633/0001209191-19-033633-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119033637/0001209191-19-033637-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119033645/0001209191-19-033645-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119035509/0001209191-19-035509-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119035513/0001209191-19-035513-index.htm
2019-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119037676/0001209191-19-037676-index.htm
2019-07-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119041824/0001209191-19-041824-index.htm
2019-07-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119041827/0001209191-19-041827-index.htm
2019-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119043685/0001209191-19-043685-index.htm
2019-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119046846/0001209191-19-046846-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119048225/0001209191-19-048225-index.htm
2019-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119049666/0001209191-19-049666-index.htm
2019-11-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119056188/0001209191-19-056188-index.htm
2019-11-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119056191/0001209191-19-056191-index.htm
2019-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119060843/0001209191-19-060843-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119061129/0001209191-19-061129-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119061132/0001209191-19-061132-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119061134/0001209191-19-061134-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119061135/0001209191-19-061135-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119061136/0001209191-19-061136-index.htm
2020-01-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120004301/0001209191-20-004301-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120004855/0001209191-20-004855-index.htm
2020-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120005129/0001209191-20-005129-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120006267/0001209191-20-006267-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120012474/0001209191-20-012474-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120012479/0001209191-20-012479-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120012484/0001209191-20-012484-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120012490/0001209191-20-012490-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120012528/0001209191-20-012528-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120014402/0001209191-20-014402-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120014464/0001209191-20-014464-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120014467/0001209191-20-014467-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120014476/0001209191-20-014476-index.htm
2020-03-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120019543/0001209191-20-019543-index.htm
2020-04-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120025240/0001209191-20-025240-index.htm
2020-04-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120025241/0001209191-20-025241-index.htm
2020-04-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120025257/0001209191-20-025257-index.htm
2020-04-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120025917/0001209191-20-025917-index.htm
2020-04-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120025918/0001209191-20-025918-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120028895/0001209191-20-028895-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120028899/0001209191-20-028899-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120028900/0001209191-20-028900-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120028903/0001209191-20-028903-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120028906/0001209191-20-028906-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120034692/0001209191-20-034692-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120034693/0001209191-20-034693-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120034694/0001209191-20-034694-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120034695/0001209191-20-034695-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120034696/0001209191-20-034696-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120034697/0001209191-20-034697-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120034699/0001209191-20-034699-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120034700/0001209191-20-034700-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120036289/0001209191-20-036289-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120037035/0001209191-20-037035-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120047469/0001209191-20-047469-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120047472/0001209191-20-047472-index.htm
2020-09-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120049868/0001209191-20-049868-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120050875/0001209191-20-050875-index.htm
2020-10-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120054621/0001209191-20-054621-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1446847/000127417320000094/0001274173-20-000094-index.htm
2019-09-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1446847/000139834419016261/0001398344-19-016261-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1446847/000139834420003413/0001398344-20-003413-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000141057819000630/0001410578-19-000630-index.htm
2019-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000141057819000770/0001410578-19-000770-index.htm
2019-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000141057819000778/0001410578-19-000778-index.htm
2019-09-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000141057819001260/0001410578-19-001260-index.htm
2019-09-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000141057819001289/0001410578-19-001289-index.htm
2019-05-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1446847/000155837019003848/0001558370-19-003848-index.htm
2019-07-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1446847/000155837019006578/0001558370-19-006578-index.htm
2019-10-3110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1446847/000155837019009567/0001558370-19-009567-index.htm
2020-02-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1446847/000155837020000779/0001558370-20-000779-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1446847/000155837020005460/0001558370-20-005460-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1446847/000155837020009637/0001558370-20-009637-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1446847/000155837020012918/0001558370-20-012918-index.htm
2019-03-19CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1446847/999999999719001495/9999999997-19-001495-index.htm
2019-04-26CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1446847/999999999719003532/9999999997-19-003532-index.htm
2019-04-26CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1446847/999999999719003534/9999999997-19-003534-index.htm

Ironwood Pharmaceuticals, Inc (IRWD) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ironwood Pharmaceuticals, Inc (IRWD). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 296%
Institutional Ownership: 10852%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-04-01Mark MallonChief Executive OfficerBuy11,500.00104,536.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023482/0001209191-19-023482-index.htm
2020-04-24Michael ShetzlineCMO, SVP & Head of Drug Devt.Buy20,740.00107,046.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120025918/0001209191-20-025918-index.htm
2019-05-10Thomas A MCCOURTPresidentSell4,055.0010.5342,699.15107,239.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119029609/0001209191-19-029609-index.htm
2020-06-03Andrew DreyfusDirectorBuy21,720.00108,658.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120034693/0001209191-20-034693-index.htm
2019-06-05Julie McHughDirectorSell1,500.0011.2616,890.00109,337.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119035509/0001209191-19-035509-index.htm
2019-08-30Thomas A MCCOURTPresidentSell220,000.009.242,032,800.00109,739.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119048225/0001209191-19-048225-index.htm
2020-06-15Andrew DreyfusDirectorBuy1,745.00110,403.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120037035/0001209191-20-037035-index.htm
2019-05-29Julie McHughDirectorBuy22,706.00110,837.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119033630/0001209191-19-033630-index.htm
2019-05-01Thomas A MCCOURTPresidentBuy22,852.00111,294.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119027346/0001209191-19-027346-index.htm
2020-09-15Andrew DreyfusDirectorBuy1,600.00112,003.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120050875/0001209191-20-050875-index.htm
2020-05-11Kelly MacDonaldChief Accounting OfficerSell595.0010.356,158.25118,147.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120028899/0001209191-20-028899-index.htm
2020-08-17Kelly MacDonaldChief Accounting OfficerSell575.0010.145,830.50118,552.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120047469/0001209191-20-047469-index.htm
2020-05-11Kelly MacDonaldChief Accounting OfficerSell558.0010.355,775.30118,742.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120028899/0001209191-20-028899-index.htm
2020-02-27Kelly MacDonaldChief Accounting OfficerBuy36,173.00119,300.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120014464/0001209191-20-014464-index.htm
2020-09-08Julie McHughDirectorSell7,950.009.7777,671.50123,107.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120049868/0001209191-20-049868-index.htm
2020-05-11Conor KilroySVP, GC & SecretarySell558.0010.355,775.30128,921.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120028895/0001209191-20-028895-index.htm
2020-05-11Conor KilroySVP, GC & SecretarySell158.0010.351,635.30129,479.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120028895/0001209191-20-028895-index.htm
2020-04-24Conor KilroySVP, GC & SecretaryBuy22,814.00129,637.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120025917/0001209191-20-025917-index.htm
2020-06-03Julie McHughDirectorBuy21,720.00131,057.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120034696/0001209191-20-034696-index.htm
2019-04-01Marsha FanucciDirectorSell4,056.00132,663.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023411/0001209191-19-023411-index.htm
2019-03-29IRONWOOD PHARMACEUTICALS INC10% Share HolderBuy15,562,455.0015,562,555.00https://www.sec.gov/Archives/edgar/data/1446847/000110465919019466/0001104659-19-019466-index.htm
2019-11-08Gina ConsylmanSVP, CFO & TreasurerSell630.0011.006,930.00174,138.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119056188/0001209191-19-056188-index.htm
2019-11-08Gina ConsylmanSVP, CFO & TreasurerSell880.0011.009,680.00174,768.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119056188/0001209191-19-056188-index.htm
2019-08-16Gina ConsylmanSVP, CFO & TreasurerSell212.009.041,916.48175,648.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119046846/0001209191-19-046846-index.htm
2019-05-10Gina ConsylmanSVP, CFO & TreasurerSell4,055.0010.5342,699.15175,860.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119029596/0001209191-19-029596-index.htm
2019-04-01Gina ConsylmanSVP, CFO & TreasurerBuy16,731.00179,915.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023430/0001209191-19-023430-index.htm
2019-05-29Edward P OwensDirectorBuy22,706.00182,234.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119033645/0001209191-19-033645-index.htm
2019-08-30Thomas A MCCOURTPresidentBuy90,000.004.88439,200.00199,739.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119048225/0001209191-19-048225-index.htm
2020-02-21Gina ConsylmanSVP, CFO & TreasurerSell6,181.0011.6371,885.03202,787.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012474/0001209191-20-012474-index.htm
2020-06-03Edward P OwensDirectorBuy21,720.00203,954.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120034700/0001209191-20-034700-index.htm
2020-02-21Gina ConsylmanSVP, CFO & TreasurerSell2,558.0011.6329,749.54208,968.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012474/0001209191-20-012474-index.htm
2020-02-21Gina ConsylmanSVP, CFO & TreasurerSell2,252.0011.6326,190.76211,526.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012474/0001209191-20-012474-index.htm
2020-02-21Gina ConsylmanSVP, CFO & TreasurerSell1,510.0011.6317,561.30213,778.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012474/0001209191-20-012474-index.htm
2019-12-16Gina ConsylmanSVP, CFO & TreasurerBuy41,150.00215,288.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119061129/0001209191-19-061129-index.htm
2020-02-21Thomas A MCCOURTPresidentSell1,865.0011.6321,689.95221,062.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012490/0001209191-20-012490-index.htm
2020-02-21Thomas A MCCOURTPresidentSell2,312.0011.6326,888.56222,927.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012490/0001209191-20-012490-index.htm
2019-12-16Thomas A MCCOURTPresidentBuy115,220.00224,959.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119061135/0001209191-19-061135-index.htm
2020-01-24Thomas A MCCOURTPresidentSell20,000.0012.71254,200.00225,239.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120005129/0001209191-20-005129-index.htm
2020-05-11Jason RickardSVP, Chief Operating OfficerSell510.0010.355,278.50234,580.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120028906/0001209191-20-028906-index.htm
2020-08-17Jason RickardSVP, Chief Operating OfficerSell689.0010.146,986.46235,776.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120047472/0001209191-20-047472-index.htm
2019-05-10Halley E GilbertChief Admin Officer & SVPSell4,055.0010.5342,699.15238,240.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119029605/0001209191-19-029605-index.htm
2019-07-26Halley E GilbertChief Admin Officer & SVPSell20,000.0010.00200,000.00240,169.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119043685/0001209191-19-043685-index.htm
2019-04-01Halley E GilbertChief Admin Officer & SVPBuy17,165.00242,295.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023431/0001209191-19-023431-index.htm
2020-01-24Thomas A MCCOURTPresidentBuy20,000.0010.02200,400.00245,239.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120005129/0001209191-20-005129-index.htm
2019-05-29Catherine MoukheibirDirectorBuy22,706.0025,701.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119033633/0001209191-19-033633-index.htm
2019-05-29Jon R DuaneDirectorBuy22,706.0025,701.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119033624/0001209191-19-033624-index.htm
2019-05-29Marla L KesslerDirectorBuy22,706.0025,701.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119033627/0001209191-19-033627-index.htm
2019-07-26Halley E GilbertChief Admin Officer & SVPBuy20,000.004.8897,600.00260,169.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119043685/0001209191-19-043685-index.htm
2019-04-01William HuyettChief Operating OfficerSell85,312.0026,063.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023429/0001209191-19-023429-index.htm
2020-02-21Halley E GilbertChief Admin Officer & SVPSell6,181.0011.6371,885.03265,991.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012479/0001209191-20-012479-index.htm
2020-02-27Gina ConsylmanSVP, CFO & TreasurerBuy68,327.00271,114.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120014402/0001209191-20-014402-index.htm
2020-02-21Halley E GilbertChief Admin Officer & SVPSell2,984.0011.6334,703.92272,172.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012479/0001209191-20-012479-index.htm
2020-02-21Halley E GilbertChief Admin Officer & SVPSell3,410.0011.6339,658.30275,156.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012479/0001209191-20-012479-index.htm
2019-04-01William HuyettChief Operating OfficerBuy1,483.0027,546.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023429/0001209191-19-023429-index.htm
2020-02-21Halley E GilbertChief Admin Officer & SVPSell2,753.0011.6332,017.39278,566.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012479/0001209191-20-012479-index.htm
2019-12-16Halley E GilbertChief Admin Officer & SVPBuy41,150.00281,319.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119061132/0001209191-19-061132-index.htm
2020-01-31Halley E GilbertChief Admin Officer & SVPSell60,000.0012.05723,000.00281,319.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120006267/0001209191-20-006267-index.htm
2019-04-01Catherine MoukheibirDirectorBuy2,995.002,995.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023463/0001209191-19-023463-index.htm
2019-04-01Jon R DuaneDirectorBuy2,995.002,995.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023457/0001209191-19-023457-index.htm
2019-04-01Marla L KesslerDirectorBuy2,995.002,995.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023459/0001209191-19-023459-index.htm
2020-02-24Mark MallonChief Executive OfficerSell1.0011.2511.25303,425.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012528/0001209191-20-012528-index.htm
2020-02-21Mark MallonChief Executive OfficerSell7,983.0011.6392,842.29303,426.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012528/0001209191-20-012528-index.htm
2019-04-01Mark MallonChief Executive OfficerBuy206,873.00311,409.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023482/0001209191-19-023482-index.htm
2020-05-11Thomas A MCCOURTPresidentSell1,697.0010.3517,563.95319,847.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120028903/0001209191-20-028903-index.htm
2020-02-27Thomas A MCCOURTPresidentBuy100,482.00321,544.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120014476/0001209191-20-014476-index.htm
2019-08-30Thomas A MCCOURTPresidentBuy130,000.004.88634,400.00329,739.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119048225/0001209191-19-048225-index.htm
2020-01-31Halley E GilbertChief Admin Officer & SVPBuy60,000.0010.02601,200.00341,319.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120006267/0001209191-20-006267-index.htm
2019-03-05LAWRENCE S OLANOFFDirectorSell2,000.0014.4128,820.0037,553.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119017301/0001209191-19-017301-index.htm
2019-04-01AMY W SCHULMANDirectorSell4,056.0038,242.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023419/0001209191-19-023419-index.htm
2019-03-15AMY W SCHULMANDirectorBuy183.0042,298.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119020265/0001209191-19-020265-index.htm
2020-06-03Catherine MoukheibirDirectorBuy21,720.0047,421.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120034697/0001209191-20-034697-index.htm
2020-06-03Jon R DuaneDirectorBuy21,720.0047,421.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120034694/0001209191-20-034694-index.htm
2020-06-03Marla L KesslerDirectorBuy21,720.0047,421.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120034695/0001209191-20-034695-index.htm
2020-05-11Mark MallonChief Executive OfficerSell23,206.0010.35240,182.10501,280.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120028900/0001209191-20-028900-index.htm
2020-02-27Mark MallonChief Executive OfficerBuy221,061.00524,486.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120014467/0001209191-20-014467-index.htm
2019-03-08Mark G CurrieChief Scientific OfficerSell49,500.0013.15650,925.00528,480.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119018232/0001209191-19-018232-index.htm
2019-05-10Mark G CurrieDirectorSell4,055.0010.5342,699.15528,903.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119029601/0001209191-19-029601-index.htm
2019-04-01Mark G CurrieDirectorBuy1,483.00529,963.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023438/0001209191-19-023438-index.htm
2019-04-01Mark G CurrieDirectorBuy2,995.00532,958.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023438/0001209191-19-023438-index.htm
2020-01-16Mark G CurrieDirectorSell8,888.0012.80113,766.40549,272.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120004301/0001209191-20-004301-index.htm
2020-01-23Mark G CurrieDirectorSell60,000.0012.59755,400.00549,272.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120004855/0001209191-20-004855-index.htm
2019-05-29Mark G CurrieDirectorBuy22,706.00551,609.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119033615/0001209191-19-033615-index.htm
2020-01-16Mark G CurrieDirectorBuy8,888.0010.0289,057.76558,160.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120004301/0001209191-20-004301-index.htm
2020-06-03Mark G CurrieDirectorBuy21,720.00570,992.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120034692/0001209191-20-034692-index.htm
2019-03-07Mark G CurrieChief Scientific OfficerSell225,500.0013.292,996,895.00577,980.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119018232/0001209191-19-018232-index.htm
2019-06-05LAWRENCE S OLANOFFDirectorSell2,000.0011.2522,500.0058,259.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119035513/0001209191-19-035513-index.htm
2019-05-29LAWRENCE S OLANOFFDirectorBuy22,706.0060,259.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119033637/0001209191-19-033637-index.htm
2020-01-23Mark G CurrieDirectorBuy60,000.009.12547,200.00609,272.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120004855/0001209191-20-004855-index.htm
2020-06-10LAWRENCE S OLANOFFDirectorSell11,350.0010.06114,181.0068,629.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120036289/0001209191-20-036289-index.htm
2019-04-01TERRANCE MCGUIREDirectorSell4,056.0073,630.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023416/0001209191-19-023416-index.htm
2019-03-15TERRANCE MCGUIREDirectorBuy183.0077,686.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119020268/0001209191-19-020268-index.htm
2019-11-08Kelly MacDonaldChief Accounting OfficerSell107.0011.001,177.0078,337.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119056191/0001209191-19-056191-index.htm
2019-11-08Kelly MacDonaldChief Accounting OfficerSell880.0011.009,680.0078,444.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119056191/0001209191-19-056191-index.htm
2019-07-09Kelly MacDonaldChief Accounting OfficerBuy7,500.0079,324.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119041827/0001209191-19-041827-index.htm
2020-06-03LAWRENCE S OLANOFFDirectorBuy21,720.0079,979.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120034699/0001209191-20-034699-index.htm
2019-05-29Andrew DreyfusDirectorBuy22,706.0080,813.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119033621/0001209191-19-033621-index.htm
2019-06-14Andrew DreyfusDirectorBuy1,567.0082,380.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119037676/0001209191-19-037676-index.htm
2020-02-21Kelly MacDonaldChief Accounting OfficerSell1,695.0011.6319,712.8583,127.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012484/0001209191-20-012484-index.htm
2019-09-13Andrew DreyfusDirectorBuy1,692.0084,072.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119049666/0001209191-19-049666-index.htm
2020-02-21Kelly MacDonaldChief Accounting OfficerSell303.0011.633,523.8984,822.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012484/0001209191-20-012484-index.htm
2020-02-21Kelly MacDonaldChief Accounting OfficerSell793.0011.639,222.5985,125.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012484/0001209191-20-012484-index.htm
2019-12-13Andrew DreyfusDirectorBuy1,270.0085,342.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119060843/0001209191-19-060843-index.htm
2020-02-21Kelly MacDonaldChief Accounting OfficerSell303.0011.633,523.8985,918.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012484/0001209191-20-012484-index.htm
2020-02-21Kelly MacDonaldChief Accounting OfficerSell504.0011.635,861.5286,221.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012484/0001209191-20-012484-index.htm
2019-12-16Kelly MacDonaldChief Accounting OfficerBuy8,230.0086,567.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119061134/0001209191-19-061134-index.htm
2020-02-21Kelly MacDonaldChief Accounting OfficerSell302.0011.633,512.2686,725.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012484/0001209191-20-012484-index.htm
2020-03-13Andrew DreyfusDirectorBuy1,596.0086,938.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120019543/0001209191-20-019543-index.htm
2019-04-01DOUGLAS E WILLIAMSDirectorSell4,056.0087,800.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023423/0001209191-19-023423-index.htm
2019-03-05Julie McHughDirectorSell1,500.0014.3821,570.0088,131.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119017305/0001209191-19-017305-index.htm
2019-04-01Thomas A MCCOURTPresidentBuy5,133.0088,442.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023433/0001209191-19-023433-index.htm
2020-10-08Kelly MacDonaldChief Accounting OfficerSell22,714.0010.50238,497.0095,838.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120054621/0001209191-20-054621-index.htm